Stakeholder Political Alliance For Radioligand Cancer Therapies

Improving tailored cancer care and patients' quality of life

SPARC-Europe is a European policy initiative aiming to build an adequate policy environment for radioligand therapies by ensuring that policy initiatives of the European Union reflect the specific characteristics of these therapies. 

Our mission

1

Provide expert knowledge to support policymakers in strengthening European cancer care

2

Guide policymakers on how to overcome the current barriers of accessibility of radioligand therapies

3

Provide the patient voice to advise experts and policymakers on how to improve patient treatment outcomes

4

Engage with relevant decision and policymakers to address the existing geographical variations in access to radioligand therapies

Steering Committee Members

Mark McDonnell

Mark McDonnell

International Neuroendocrine Cancer Alliance
Andre Deschamps

Andre Deschamps

Europa Uomo
Prof. Ken Herrmann

Prof. Ken Herrmann

University Hospital Essen
Prof. Dermot O‘Toole

Prof. Dermot O‘Toole

Trinity College Dublin
Prof. Martyn Caplin

Prof. Martyn Caplin

Royal Free Hospital and University College London
Dr. Nicola Fazio

Dr. Nicola Fazio

European Institute of Oncology
Dr. Luka Ležaić

Dr. Luka Ležaić

University Medical Centre Ljubljana
Prof. Ignasi Carrió

Prof. Ignasi Carrió

Autonomous University of Barcelona, Research Institute, Hospital Sant Pau

Latest publications

Improving European policies to unlock radioligand therapies’ potential: what is the state of play?

The event will serve as an opportunity to take stock of progress made thus far in the field of cancer care at the EU level. The implementation of Europe’s Beating Cancer Plan in synergy with other EU healthcare initiatives such as the SAMIRA Action Plan, EU4Health programme or Horizon Europe, prove…

Launch of Investment Pathway Guide & Patient Testimonials

SPARC-Europe launches two materials developed to further raise awareness about the challenges related to the delivery of radioligand therapies: a video featuring testimonials of patients who underwent a radioligand therapy treatment and Investment Pathway Guide, which lays down the needs for…

Launch of SPARC-Europe position paper on improving access to radioligand therapies

SPARC-Europe launches its very first High-Level Position Paper on Radioligand Cancer Therapies. This publication is a comprehensive overview of the barriers to the accessibility of radioligand therapies and presents recommendations how to overcome them in the context of European policies.